Report of Foreign Issuer (6-k)
28 March 2020 - 12:10AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 6-K
REPORT OF
FOREIGN PRIVATE ISSUER PURSUANT
TO RULE 13a-16 or 15d-16 UNDER THE
SECURITIES EXCHANGE ACT OF 1934
For the month of March, 2020
Commission File Number: 001-38452
MEREO
BIOPHARMA GROUP PLC
(Translation of registrants name into English)
4th Floor, One Cavendish Place,
London, W1G 0QF, United Kingdom
(Address of principal executive office)
Indicate by check mark whether
the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form
20-F ☒ Form 40-F ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐
Exhibit Index
|
|
|
Exhibit
No.
|
|
Exhibit
|
|
|
99.1
|
|
Press release dated March 27, 2020
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned, thereunto duly authorized.
Date: March 27, 2020
|
|
|
MEREO BIOPHARMA GROUP PLC
|
|
|
By:
|
|
/s/ Charles Sermon
|
Name:
|
|
Charles Sermon
|
Title:
|
|
General Counsel
|
Mereo BioPharma (NASDAQ:MREO)
Historical Stock Chart
From Sep 2024 to Oct 2024
Mereo BioPharma (NASDAQ:MREO)
Historical Stock Chart
From Oct 2023 to Oct 2024